Spectral AI, Inc.
$1.89
▲
0.69%
2026-04-21 08:05:01
www.spectral-ai.com
NCM: MDAI
Explore Spectral AI, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$60.15 M
Current Price
$1.89
52W High / Low
$3.21 / $1.13
Stock P/E
—
Book Value
$-0.19
Dividend Yield
—
ROCE
-1104.36%
ROE
116.67%
Face Value
—
EPS
$-0.29
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
65
Beta
0.91
Debt / Equity
-1.76
Current Ratio
0.94
Quick Ratio
0.9
Forward P/E
-2.01
Price / Sales
2.8
Enterprise Value
$49.76 M
EV / EBITDA
-5.83
EV / Revenue
2.53
Rating
Strong Buy
Target Price
$4.67
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 2. | NeuroPace, Inc. | $16.53 | — | $545.07 M | — | -18.62% | -1.59% | $18.98 / $7.56 | $0.57 |
| 3. | Quanterix Corporation | $3.3 | — | $164.29 M | — | -31.92% | -34.25% | $8.77 / $3.23 | $6.33 |
| 4. | Biomerica, Inc. | $2.18 | — | $6.74 M | — | -122.16% | -84.3% | $4.6 / $1.87 | $1.5 |
| 5. | InfuSystem Holdings, Inc. | $10.79 | 32.21 | $213.43 M | — | 14.83% | 11.54% | $11.04 / $4.66 | $2.84 |
| 6. | Masimo Corporation | $178.4 | 46.03 | $9.34 B | — | 23.57% | 23.43% | $179 / $125.94 | $13.84 |
| 7. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 4.09 M | 3.79 M | 5.07 M | 6.71 M | 7.6 M | — |
| Operating Profit | -2.24 M | -3.34 M | -2.12 M | -0.9 M | -1.11 M | — |
| Net Profit | 1.05 M | -3.55 M | -7.97 M | 2.9 M | -7.74 M | — |
| EPS in Rs | 0.03 | -0.11 | -0.25 | 0.09 | -0.24 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 19.65 M | 29.58 M | 18.06 M | 25.37 M |
| Operating Profit | -8.6 M | -6.58 M | -12.98 M | -2.65 M |
| Net Profit | -7.57 M | -15.16 M | -20.85 M | -2.91 M |
| EPS in Rs | -0.24 | -0.48 | -0.66 | -0.09 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 21.41 M | 12.1 M | 10.69 M | 18.72 M |
| Total Liabilities | 27.13 M | 19.35 M | 12.4 M | 6.72 M |
| Equity | -5.73 M | -7.25 M | -1.71 M | 12 M |
| Current Assets | 19.45 M | 10.12 M | 9.9 M | 17.69 M |
| Current Liabilities | 20.63 M | 17.64 M | 12.4 M | 6.37 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -9.92 M | -9.2 M | -13.24 M | -1.16 M |
| Investing CF | — | — | — | 0 M |
| Financing CF | 20.12 M | 9.57 M | 3.84 M | -0.79 M |
| Free CF | -9.92 M | -9.2 M | -13.24 M | -1.16 M |
| Capex | — | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 63.83% | -28.82% | — | — |
| Earnings Growth % | 27.31% | -616.14% | — | — |
| Profit Margin % | -51.24% | -115.5% | -11.48% | — |
| Operating Margin % | -22.25% | -71.91% | -10.43% | — |
| Gross Margin % | 44.87% | 43.64% | 42.72% | — |
| EBITDA Margin % | -38.85% | -111.44% | -8.2% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.